Cargando…

Hypernatremia in a patient treated with sodium polystyrene sulfonate

Severe hyperkalemia requires urgent medical attention and correction in order to prevent arrhythmic complications. Sodium polystyrene sulfonate (SPS) is a cation exchange resin commonly used in the management of hyperkalemia. A recent review raised concerns regarding its effectiveness and potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Nepal, Manish, Bucaloiu, Ion Dan, Norfolk, Evan R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108779/
https://www.ncbi.nlm.nih.gov/pubmed/21694940
http://dx.doi.org/10.2147/IJNRD.S13871
_version_ 1782205373473619968
author Nepal, Manish
Bucaloiu, Ion Dan
Norfolk, Evan R
author_facet Nepal, Manish
Bucaloiu, Ion Dan
Norfolk, Evan R
author_sort Nepal, Manish
collection PubMed
description Severe hyperkalemia requires urgent medical attention and correction in order to prevent arrhythmic complications. Sodium polystyrene sulfonate (SPS) is a cation exchange resin commonly used in the management of hyperkalemia. A recent review raised concerns regarding its effectiveness and potential adverse effects. Hypernatremia in adults in the setting of sodium polystyrene sulfonate therapy has not been described in the literature. We report the case of a woman who developed hypernatremia in the setting of excessive SPS administration and hope to increase awareness among clinicians regarding this potential side effect of SPS therapy.
format Online
Article
Text
id pubmed-3108779
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-31087792011-06-21 Hypernatremia in a patient treated with sodium polystyrene sulfonate Nepal, Manish Bucaloiu, Ion Dan Norfolk, Evan R Int J Nephrol Renovasc Dis Case Report Severe hyperkalemia requires urgent medical attention and correction in order to prevent arrhythmic complications. Sodium polystyrene sulfonate (SPS) is a cation exchange resin commonly used in the management of hyperkalemia. A recent review raised concerns regarding its effectiveness and potential adverse effects. Hypernatremia in adults in the setting of sodium polystyrene sulfonate therapy has not been described in the literature. We report the case of a woman who developed hypernatremia in the setting of excessive SPS administration and hope to increase awareness among clinicians regarding this potential side effect of SPS therapy. Dove Medical Press 2010-11-16 /pmc/articles/PMC3108779/ /pubmed/21694940 http://dx.doi.org/10.2147/IJNRD.S13871 Text en © 2010 Nepal et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Case Report
Nepal, Manish
Bucaloiu, Ion Dan
Norfolk, Evan R
Hypernatremia in a patient treated with sodium polystyrene sulfonate
title Hypernatremia in a patient treated with sodium polystyrene sulfonate
title_full Hypernatremia in a patient treated with sodium polystyrene sulfonate
title_fullStr Hypernatremia in a patient treated with sodium polystyrene sulfonate
title_full_unstemmed Hypernatremia in a patient treated with sodium polystyrene sulfonate
title_short Hypernatremia in a patient treated with sodium polystyrene sulfonate
title_sort hypernatremia in a patient treated with sodium polystyrene sulfonate
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108779/
https://www.ncbi.nlm.nih.gov/pubmed/21694940
http://dx.doi.org/10.2147/IJNRD.S13871
work_keys_str_mv AT nepalmanish hypernatremiainapatienttreatedwithsodiumpolystyrenesulfonate
AT bucaloiuiondan hypernatremiainapatienttreatedwithsodiumpolystyrenesulfonate
AT norfolkevanr hypernatremiainapatienttreatedwithsodiumpolystyrenesulfonate